Investor Ideas Potcasts, Cannabis News and Stocks on the Move: (TSXV: KHRN) (CSE: XCX) (CSE: CNNA) (TSX: VFF) (NYSE: ACB)
Delta, Kelowna, BC - September 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts, #Cannabis News and Stocks on the Move: (TSXV: KHRN) (CSE: XCX) (CSE: CNNA) (TSX: VFF) (NYSE: ACB)
In today's podcast we look at a few early announcements.
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) announced today that it has commenced construction of a 9,800 m2 (105,486 sq.ft) cultivation and processing facility in Juan Lacaze, Uruguay. With a production capacity of 17 tons per year, the Company's investment in this state-of-the-art facility represents a significant increase in Khiron's total production capacity, strengthening its ability to export and supply cannabis to key international markets, including Brazil and Europe. Construction is underway and is scheduled for completion in mid Q3 2020
Located strategically within an hour's distance from the international airport and port, the facility will include 8,000 m2 of covered area for cultivation, where controlled conditions of irrigation, temperature, humidity and light will be implemented for optimum crop development. An 1,800 m2 processing plant will also be built on site for drying and processing crops, with pharmaceutical-grade design standards in place to ensure quality control across the analysis process. The cultivation area and processing plant will be built to meet the requirements of Good Agricultural Practices (GAP) and Good Manufacturing Practices (GMP), respectively, in keeping with Khiron's continued expertise and core commitment to regulatory and operational compliance.
Alvaro Torres, CEO and Director of Khiron Life Sciences, commented: "With construction of our facility in Juan Lacaze, we are actively executing on our strategy to build a dominant position in Latin America and further expand our global reach. Through its inclusion in the Mercosur trade bloc, Uruguay is poised to become a key source to supply the global medical cannabis industry. Our production in the country will target domestic use in Uruguay and export across one of the world's largest trading blocs, beginning with export to Brazil, home to 208 million people, and from there, we expect to move quickly across the bloc's trading countries in Latin America."
Uruguay was the first country globally to establish cannabis legislation. Building upon Khiron's previously announced acquisition of NettaGrowth International Inc. and its wholly-owned subsidiary Dormul S.A., which obtained the first licence in Uruguay to produce and export medical cannabis with THC for commercialization, the Company is now initiating construction of the cultivation and processing facility. Khiron has also begun pre-clinical studies in the country as part of an initiative co-sponsored by the government of Uruguay using the Company's strains. Identified as one of the most significant private-public medical cannabis studies underway in Latin America, the research program has received matching government funding for its medical innovation.
AMP German Cannabis Group Inc. (formerly "Chinook Tyee Industry Limited") (CSE: XCX) announced the commencement of trading of its common shares on the Canadian Securities Exchange (CSE). The Company's common shares were delisted from the TSX Venture Exchange at the close of market on September 3, 2019. The Company also announces that it has updated investment policy to enhance shareholder value from investments in the European medical cannabis industry.
Specifically, the Company invests in businesses that supply the German market with European Union - Good Manufacturing Practices ("EU-GMP") certified medical cannabis. The Company's medical cannabis investment portfolio consists of AMP Alternative Medical Products GmbH ("AMP Germany"), whose business is to purchase EU-GMP certified medical cannabis from Canada for distribution in Germany, and Alternative Medical Products Switzerland GmbH ("AMP Switzerland"), whose business is to develop agreements to supply the German market with cannabis cultivated from Switzerland.
Mr. Alex Blodgett, CEO of AMP commented "AMP's current European investments in the medical cannabis industry have been made to supply Germany with EU-GMP cannabis which has been forecasted to be a $9-billion market by 2028. AMP is the only listed company that focuses solely on supplying Germany with EU-GMP medical cannabis."
Dr. Stefan Feuerstein, Managing Director of AMP Germany commented, "AMP Germany plans to be a significant importer of EU-GMP cannabis to Germany from Canada. Canada has become the second largest supplier of EU-GMP cannabis to Germany since legalization of medical cannabis in 2017."
Mr. Claudio Morandi, Managing Director of AMP Switzerland commented, "It is legal to cultivate cannabis with THC <1.0% in Switzerland, which has created an emerging cannabis industry. AMP Switzerland is developing sources of nutraceutical and EU-GMP cannabis for export to Germany once applicable laws permit such transactions."
On April 23rd, 2019, CannaOne Technologies announced a formal partnership with Real Life Sciences to launch and operate the BWell CBD online marketplace in the US. Under the terms of this agreement Real Life Sciences acted as local managing partners for the BWell online marketplace providing strategic management, financial and business development expertise. As the managing partner of the BWell Marketplace, Real Life Sciences maintained a 75.1% ownership interest.
CannaOne Technologies CEO, Mr. Riby-Williams, commented "Real Life Sciences' expertise, vast network and strong relationships within the US has brought substantial value to the BWell marketplace during the past months and has been a key factor in the early launch for the business. BWell (www.thebwellmarket.com) is now capable of immediate sale and delivery of 140 high quality CBD products at extremely competitive prices to thousands of potential households in US. We believe that this infrastructure and knowledge contributed by Real Life Sciences to date provides substantial baseline support towards our Company now acquiring a sole ownership stake in the BWell marketplace that will assist to potentially provide long term substantial value to our shareholders."
Under the terms of the LOI, following an extended period of Due Diligence, CannaOne Technologies has agreed to purchase Real Life Sciences for $2,000,000 CAD, such payment to be made in full through the issuance Company shares priced at a 20% discount to the market as at the date of Closing. The Closing Date for this transaction is set for October 25, 2019.
Village Farms International, Inc. (TSX: VFF) (NASDAQ: VFF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has entered into a supply agreement with the British Columbia Liquor Distribution Branch (BCLDB) to supply the BCLDB with Pure Sunfarms-branded cannabis products for the recreational market in the Province of British Columbia.
Pure Sunfarms will begin shipping packaged product to the BCLDB, as well as the Ontario Cannabis Retail Corporation (the "OCRC", operating as the Ontario Cannabis Store), with whom it entered into a supply agreement in February 2019, as soon as possible upon receipt of its license amendment permitting sales and distribution directly to provincial/territorial wholesalers and authorized private retailers in accordance with provincial/territorial frameworks in Canada (sometimes referred to as a "packaging license").
Combined, Ontario and British Columbia comprise more than half of Canada's population, with Ontario (Canada's most populated province) and British Columbia (Canada's third most populated province) comprising more than 38% and more than 13% of Canada's population, respectively). Pure Sunfarms also continues to advance discussions with other provincial distributors for potential supply agreements.
"The announcement of today's supply agreement with the BCLDB represents a major milestone for Pure Sunfarms," said Mandesh Dosanjh, President and Chief Executive Officer, Pure Sunfarms. "We are proudly B.C.-based, cultivating cannabis to the highest standards by the most experienced growers in the industry, and look forward to having Pure Sunfarms product available in our home province."
"Pure Sunfarms is already one of Canada's largest cannabis producers, with an outstanding reputation for quality, consistency, safety and reliability," said Michael DeGiglio, CEO, Village Farms International. "This supply agreement for Canada's third most populous province will significantly expand Pure Sunfarms' market reach when it begins sales directly to provincial and territorial wholesalers, taking the next step in establishing Pure Sunfarms as a premiere national brand with Canadian cannabis consumers."
Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) announced today that on September 3, 2019, Aurora disposed of its remaining 28,833,334 shares, representing 10.5% of the issued and outstanding shares of The Green Organic Dutchman Holdings Ltd ("TGOD"), at a price of $3.00 per share for aggregate gross proceeds of $86.5 million. The completion of the sale of TGOD shares represents an approximate 50% internal rate of return for the Company. As a result of this transaction, Aurora no longer holds any shares of TGOD, however does continue to hold warrants to purchase 16,666,667 shares of TGOD.
"Aurora has a broad portfolio of strategic investments that allow us to participate in opportunities throughout the cannabis sector, while providing the company with non-dilutive access to capital," said Terry Booth, CEO of Aurora. "We evaluate our investment portfolio on a regular basis to make sure it continues to align with our investment strategy and corporate priorities. When we acquired Whistler Medical Marijuana Corporation - an iconic and premium organic cannabis producer - our interest in TGOD became less important to our core strategy. Our return on our TGOD investment is significant and will add non-dilutive capital and further enhance our strategy to remain a dominant force in the global cannabis industry."
Today's podcast Sponsor:
Today's podcast was sponsored by CBDollars. CBDollars is the first group of its kind designed to turn everyday people into entrepreneurs of one the largest, most profitable industries that will ever happen in this country. CBDollars will teach its members how to invest in the cannabis industry through stocks, ETFs, and as Angel Investors; start a wholesale store for a brick and mortar business; start an online store as a dropshipper; private label your own products from edibles to beauty & More. Join CBDOLLARS to lean more. https://www.facebook.com/groups/2117105128415627/
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Todays podcast was sponsored by CBDollars.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media
Download our Mobile App for iPhone and Android